The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Safety of trastuzumab, alone or in combination, in elderly patients with HER2-positive breast cancer: A 5-year case series.
Vincenzo Adamo
No relevant relationships to disclose
Giuseppina R. R. Ricciardi
No relevant relationships to disclose
Barbara Adamo
No relevant relationships to disclose
Giuseppa Ferraro
No relevant relationships to disclose
Tindara Franchina
No relevant relationships to disclose
Rosalba Rossello
No relevant relationships to disclose
Mariangela Zanghì
No relevant relationships to disclose
Antonio Russo
No relevant relationships to disclose
Maria Rosaria Valerio
No relevant relationships to disclose
Nicola Caristi
No relevant relationships to disclose